The largest holder of Humana stock is Dodge & Cox, with 10.9 million shares (9.11% of the company), worth about $4.19 billion as of September 25, 2026. The 10 largest holders together own 47.4%.
In Q2 2026, 999 institutional holdings reports listed shares worth $47.40 billion.
Insiders reported 69 transactions in the last two years: 1 sale worth $948,925 and 2 purchases. The newest one on file is from September 1, 2026 (Nundy Shantanu M.D., Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 1, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Dodge & Cox | 10.9 million | 9.11% | $4.2B |
| BlackRock Advisors LLC | 7.9 million | 6.59% | $3.0B |
| Vanguard Capital Management LLC | 7.8 million | 6.53% | $3.0B |
| Vanguard Portfolio Management LLC | 5.8 million | 4.85% | $2.2B |
| State Street Corporation | 5.5 million | 4.54% | $2.1B |
| Pzena Investment Management, Inc. | 4.4 million | 3.67% | $1.7B |
| Eagle Capital Management LLC | 3.8 million | 3.20% | $1.5B |
| Sessa Capital IM LP | 3.7 million | 3.10% | $1.4B |
| MFS Investment Management Canada Ltd. | 3.6 million | 2.98% | $1.4B |
| Geode Capital Management LLC | 3.4 million | 2.81% | $1.3B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 999 | – | $47.4B |
| Q1 2026 | 851 | 115.0 million | $20.0B |
| Q4 2025 | 938 | 121.0 million | $30.9B |
| Q3 2025 | 982 | 118.0 million | $30.8B |
| Q2 2025 | 956 | 115.0 million | $28.0B |
| Q1 2025 | 986 | 114.0 million | $30.2B |
| Q4 2024 | 972 | 116.0 million | $29.5B |
| Q3 2024 | 1,031 | 116.0 million | $37.1B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Nundy Shantanu M.D. | Sep 1, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Crawford Frederick John | Jul 31, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Smith Paul John | Jul 31, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Ventura Joseph Christopher | May 1, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| O'Hara Michelle A. | May 1, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Shetty Sanjay K | May 1, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Rechtin James A. | May 1, 2026 | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Dintenfass David | May 1, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Mehta Japan | May 1, 2026 | Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Mellet Celeste | May 1, 2026 | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Martin Aaron | May 1, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Field Robert Stuart | May 1, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 69 insider transactions in the last two years.
Dodge & Cox, with 9.11% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.59%) and Vanguard Capital Management LLC (6.53%).
999 institutional holdings reports listed Humana shares in Q2 2026 worth $47.40 billion.
In the last two years insiders reported 1 sale and 2 purchases (69 transactions in all); the newest on file is from September 1, 2026.